Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000366080

Medchemexpress LLC Deucravacitinib | 1609392-27-9 | 99.9% | 425.46 | 200 MG
SDP

Catalog No. 5000366080
Encompass_Preferred

Deucravacitinib is a highly selective, orally bioavailable allosteric TYK2 inhibitor designed for the treatment of autoimmune diseases. It works by selectively binding to the TYK2 pseudokinase (JH2) domain, which blocks receptor-mediated Tyk2 activation by stabilizing its regulatory JH2 domain. This action inhibits IL-12/23 and type I IFN pathways. It is used for studying moderate to severe plaque psoriasis.

  • Highly selective, orally bioavailable allosteric TYK2 inhibitor
  • Designed for the treatment of autoimmune diseases
  • Selectively binds to the TYK2 pseudokinase (JH2) domain
  • Blocks receptor-mediated Tyk2 activation
  • Inhibits IL-12/23 and type I IFN pathways
  • Used for studying moderate to severe plaque psoriasis
  • FDA's first de novo deuterium

Catalog No. 50-003-66080 Supplier Medchemexpress LLC Supplier No. 200MGHY117287
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Deucravacitinib is a highly selective, orally bioavailable allosteric TYK2 inhibitor designed for the treatment of autoimmune diseases. It works by selectively binding to the TYK2 pseudokinase (JH2) domain, which blocks receptor-mediated Tyk2 activation by stabilizing its regulatory JH2 domain. This action inhibits IL-12/23 and type I IFN pathways. It is used for studying moderate to severe plaque psoriasis.

  • Highly selective, orally bioavailable allosteric TYK2 inhibitor
  • Designed for the treatment of autoimmune diseases
  • Selectively binds to the TYK2 pseudokinase (JH2) domain
  • Blocks receptor-mediated Tyk2 activation
  • Inhibits IL-12/23 and type I IFN pathways
  • Used for studying moderate to severe plaque psoriasis
  • FDA's first de novo deuterium

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.